# Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)

> **NCT03697993** · PHASE4 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 62 (actual)

## Conditions studied

- Urinary Tract Infection

## Interventions

- **DRUG:** Fosfomycin tromethamine
- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT03697993
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-07
- **Primary completion:** 2019-10-24
- **Final completion:** 2019-10-24
- **Target enrollment:** 62 (ACTUAL)
- **Why stopped:** inadequate enrollment.
- **Last updated:** 2020-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03697993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03697993, "Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03697993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*